Seeing Cancer as a Chronic Illness
Amy Selly, CNP, AOCNP, discusses how cancer as a chronic illness impacts definitions of survivorship.
In recent years, there has been a growing recognition that cancer is increasingly becoming a chronic illness for many patients. This shift in perspective is driven by several factors. Advances in cancer research and treatment have led to higher survival rates and longer life expectancies for many types of cancer. This means that more patients are living with cancer for extended periods. As survival rates improve, there is a greater emphasis on ensuring that patients maintain a good quality of life during and after treatment. This includes addressing physical, emotional, and social challenges. Some cancers, such as prostate, breast, and thyroid cancer, are often diagnosed at early stages and can be managed as chronic conditions, requiring ongoing monitoring and treatment.
Overall, the shift towards viewing cancer as a chronic illness reflects a more nuanced understanding of the disease and a greater focus on improving the quality of life for patients.
Here, Amy Selly, CNP, AOCNP, Allina Health medical oncology advanced practice provider lead, discusses how cancer as a chronic illness impacts definitions of survivorship.
Transcription:
0:05 | I think that just encompasses survivors as as truly, yes, not only including curative intent. And so really trying to broaden that definition, which has been broad, but I think it's more getting people to to accept it, right, to use that as a more accepted terminology. And survivorship too, is it is a term that, you know, patients in particular sometimes struggle with. There's some language that is hard for patients, and sometimes that survivor language is hard.
0:42 | We often talk about patients living with cancer now as a chronic illness, because we are seeing patients who have what, you know, is a stage IV diagnosis that are living years and decades beyond and with some medication management, and even sometimes with just observation. We really are seeing those longer-term cancer survivors and and the unique needs that are coming with the treatments that are helping patients live longer.
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis
December 10th 2024In an interview, Palak Dave discussed how artificial intelligence, using deep learning to analyze bone marrow aspirate smear images, could standardize and accelerate the diagnosis of MDS vs pre-MDS conditions.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More
